Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Emerging Infections Program (EIP). EIP is a population-based surveillance activity conducted via active, laboratory case finding that is used for detecting, identifying, and monitoring emerging pathogens.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 39 (Tuesday, February 27, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 39 (Tuesday, February 27, 2024)]
[Notices]
[Pages 14501-14503]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-03889]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-24-0978; Docket No. CDC-2024-0013]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Emerging Infections Program
(EIP). EIP is a population-based surveillance activity conducted via
active, laboratory case finding that is used for detecting,
identifying, and monitoring emerging pathogens.
DATES: CDC must receive written comments on or before April 29, 2024.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0013 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: <a href="/cdn-cgi/l/email-protection#82edefe0c2e1e6e1ace5edf4"><span class="__cf_email__" data-cfemail="0867656a486b6c6b266f677e">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
[[Page 14502]]
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Emerging Infections Program (EIP) (OMB Control No. 0920-0978, Exp.
2/28/2026)--Revision--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Emerging Infections Programs (EIPs) are population-based
centers of excellence established through a network of state health
departments collaborating with academic institutions; local health
departments; public health and clinical laboratories; infection control
professionals; and healthcare providers. EIPs assist in local, state,
and national efforts to prevent, control, and monitor the public health
impact of infectious diseases. Activities of the EIPs fall into the
following general categories: (1) active surveillance; (2) applied
public health epidemiologic and laboratory activities; (3)
implementation and evaluation of pilot prevention/intervention
projects; and (4) flexible response to public health emergencies.
Activities of the EIPs are designed to: (1) address issues that the EIP
network is particularly suited to investigate; (2) maintain sufficient
flexibility for emergency response and new problems as they arise; (3)
develop and evaluate public health interventions to inform public
health policy and treatment guidelines; (4) incorporate training as a
key function; and (5) prioritize projects that lead directly to the
prevention of disease.
A Revision is being submitted to make existing collection
instruments clearer, consolidate forms and to add new forms. These
forms will allow the EIP to better detect, identify, track changes in
laboratory testing methodology, gather information about laboratory
utilization in the EIP catchment area to ensure that all cases are
being captured, and survey EIP staff to evaluate program quality.
CDC requests OMB approval for an estimated 42,440 annual burden
hours. There is no cost to respondents other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Current total
Type of respondent Form number Form name respondents responses per response (in burden (in
respondent hours) hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
State Health Department................... ABC.100.1 ABCs Case Report Form....... 10 809 20/60 2697
ABC.100.2 ABCs Invasive Pneumococcal 10 127 10/60 212
Disease in Children and
Adults Case Report Form.
ABC.100.3 ABCs H. influenzae Neonatal 10 6 10/60 10
Sepsis Expanded
Surveillance Form.
ABC.100.4 ABCs Severe GAS Infection 10 136 20/60 453
Supplemental Form.
ABC.100.5 ABCs Neonatal Infection 10 37 20/60 123
Expanded Tracking Form.
FN.200.1 FoodNet Campylobacter....... 10 970 21/60 3395
FN.200.2 FoodNet Cyclospora.......... 10 42 10/60 70
FN.200.3 FoodNet Listeria 10 16 20/60 53
monocytogenes.
FN.200.4 FoodNet Salmonella.......... 10 855 21/60 2993
FN.200.5 FoodNet Shiga toxin 10 290 20/60 967
producing E. coli.
FN.200.6 FoodNet Shigella............ 10 234 10/60 390
FN.200.7 FoodNet Vibrio.............. 10 46 10/60 77
FN.200.8 FoodNet Yersinia............ 10 55 10/60 92
FN.200.9 FoodNet Hemolytic Uremic 10 10 1 100
Syndrome.
FN.200.10 FoodNet Clinical Laboratory 10 70 10/60 117
Practices and Testing
Volume.
FSN.300.1 FluSurv-Net Influenza 15 727 25/60 4544
Hospitalization
Surveillance Network Case
Report Form.
FSN.300.2 FluSurv-Net Influenza 14 16 10/60 37
Hospitalization
Surveillance Project
Vaccination Phone Script
and Consent Form (English/
Spanish).
FSN.300.3 FluSurv-Net Influenza 14 126 5/60 147
Hospitalization
Surveillance Project
Provider Vaccination
History Fax Form (Children/
Adults).
FSN.300.4 FluSurv-NET Laboratory 15 16 10/60 40
Survey.
HAIC.400.1 HAIC--Multi-site Gram- 11 1581 29/60 8406
Negative Surveillance
Initiative (MuGSI) Case
Report Form.
HAIC.400.2 HAIC MuGSI CA CP-CRE Health 10 10 30/60 50
interview.
HAIC.400.3 HAIC MuGSI Supplemental 11 1 20/60 4
Surveillance Officer Survey.
HAIC.400.4 HAIC--Invasive 10 788 29/60 3809
Staphylococcus aureus
Infection Case Report Form.
HAIC.400.5 HAIC--Invasive 10 11 9/60 17
Staphylococcus aureus
Laboratory Survey.
HAIC.400.6 HAIC--Invasive 10 1 10.5/60 2
Staphylococcus aureus
Supplemental Surveillance
Officers Survey.
[[Page 14503]]
HAIC.400.7 HAIC--CDI Case Report and 10 1650 38/60 10450
Treatment Form.
HAIC.400.8 HAIC--Annual Survey of 10 16 17/60 45
Laboratory Testing
Practices for C. difficile
Infections.
HAIC.400.9 HAIC--CDI Annual 10 1 15/60 3
Surveillance Officers
Survey.
HAIC.400.10 HAIC--Emerging Infections 10 45 5/60 38
Program C. difficile
Surveillance Nursing Home
Telephone Survey (LTCF).
HAIC.400.11 HAIC Candidemia Case Report 10 170 40/60 1133
Form.
HAIC.400.12 HAIC--Laboratory Testing 10 20 14/60 47
Practices for Candidemia
Questionnaire.
HAIC.400.13 HAIC Death Ascertainment 10 8 1440/60 1,920
Project.
---------------------------------------------------------------
Total................................. .............. ............................ .............. .............. .............. 42,440
--------------------------------------------------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-03889 Filed 2-26-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.